Galapagos NV expected to post a loss of 14 cents a share - Earnings Preview

Lakefront Biotherapeutics NV

30/04/2024 12:01

* Galapagos NV  GLPG.AS   is expected to report results on
May 2
for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Galapagos NV is for a
loss
of 14 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 10
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Galapagos
NV is
€40.00​, above​ its last closing price of €26.76. ​​​

This summary was machine generated April 30 at 11:01 GMT.  All
figures in euros unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)